DP
Therapeutic Areas
Ten Boron Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TB0010 | Recurrent head and neck carcinomas | Phase 1b |
| Novel BPA Formulation | Not specified (BNCT) | Pre-clinical |
| Additional Carrier Program 1 | Not specified | Pre-clinical |
| Additional Carrier Program 2 | Not specified | Pre-clinical |